The Valley Desk

NCT00025467 · Interventional trial

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Overall registry status Completed

Phase 2

Conditions Endometrial Adenoacanthoma, Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov